Stockscreener 앱 받기
137.40
0.49%
-0.68
시장 영업 전:
137.75
0.35
+0.25%
Abbott Laboratories 주식(ABT)의 최신 뉴스
India Medical Nutrition Market Future Trends and Scope Analysis - openPR.com
Abbott, MSD Forge Diabetes‑Drug Pact For Wider Indian Reach - BW Healthcare World
Abbott Labs stock price target maintained at $140 by Oppenheimer - Investing.com India
Leerink Partners Begins Coverage on ABT - Insider Monkey
10 Best Dividend Stocks to Buy for Dependable Dividend Growth - Insider Monkey
Who Rules Homecare Clinical Nutrition Market? Abbott, Danone, - openPR.com
Health Canada approves Abbott’s i-STAT TBI test for suspected concussions - Medical Device Network
Abbott, Tandem Diabetes Care Partner For Glucose-Ketone Sensor for Diabetes Management - Insider Monkey
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q1 Earnings? - FinancialContent
Abbott (ABT) Stock Dips While Market Gains: Key Facts - Nasdaq
Eaton makes a move outside of the data center — plus, what's new with Abbott Labs - CNBC
Abbott Wins Dismissal of Whistleblower’s Medicare Fraud Suit - Bloomberg Law News
Abbott Declares 406th Consecutive Quarterly Dividend - marketscreener.com
Abbott Laboratories' Whole Blood Concussion Test Approved by Health Canada - marketscreener.com
Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions - Barchart.com
Blood Screening Market Outlook | Key Players: Abbott Laboratories, Roche, Grifols, BioMérieux - openPR.com
Deep Venous Disease Treatment Market Key Players Analysis - openPR.com
1 Unpopular Stock that Should Get More Attention and 2 to Avoid - FinancialContent
Jim Cramer Calls Abbott “Really Excellent” - Insider Monkey
Electrophysiology Devices Market Share Leaders: Abbott, Acutus Medical, and Biosense Webster - openPR.com
Abbott Laboratories (ABT) Maintains Quarterly Dividend of $0.59 - GuruFocus
Abbott Declares 406Th Consecutive Quarterly Dividend, Payable on August 15, 2025 - marketscreener.com
Piper Sandler names Abbott, Edwards, Glaukos as top medtech catalyst picks - Investing.com Nigeria
Abbott Laboratories Keeps Quarterly Dividend at $0.59 per Share, Payable August 15 to Shareholders as of July 15 - marketscreener.com
Clinical Immunochemistry Analyzers Market projected reach USD 6.9 billion by 2034, growing at a CAGR of 4.4% | Exactitude Consultancy - GlobeNewswire Inc.
Abbott Laboratories Stock Sees RS Rating Rise To 82 - Investor's Business Daily
Stocks To Watch: Abbott Laboratories Sees RS Rating Rise To 82 - MSN
Abbott and Medtronic best positioned manufacturers in US neurology market - PharmaLive
Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions - simplywall.st
Tandem, Abbott team on insulin delivery with glucose-ketone sensor - MedTech Dive
Tandem Diabetes (TNDM) Partners with Abbott for Innovative Diabe - GuruFocus
Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor - Seeking Alpha
Abbott (ABT) Partners with Tandem Diabetes for Advanced Diabetes Management Solutions | ABT Stock News - GuruFocus
3 Low-Volatility Stocks in Hot Water - FinancialContent
Abbott Laboratories Stock: Is ABT Outperforming the Health Care Sector? - MSN
Abbott Laboratories (ABT) Stock Dips Slightly on NYSE, Long-Term Gains Remain Solid - Daily Chhattisgarh News
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance
Thousands of lawsuits over baby formula should stay where filed, court says - Reuters
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Test Strip Market Is Booming So Rapidly 2025-2032 -Abbott - openPR.com
Abbott Announces FDA Approval Of Tendyne Transcatheter Mitral Valve Replacement System - insights.citeline.com
Abbott Laboratories Stock: Is ABT Outperforming The Health Care Sector? - Barchart.com
Goldman Sachs Adjusts Price Target on Abbott Laboratories to $153 From $147, Maintains Buy Rating - marketscreener.com
There's Been No Shortage Of Growth Recently For Abbott Laboratories' (NYSE:ABT) Returns On Capital - Yahoo Finance
Abbott Tendyne TMVR secures FDA clearance - BioWorld MedTech
Cardiac Marker Analyzer Market Is Booming WorldwideAbbott, Roche Diagnostics - openPR.com
Abbott Labs (ABT) Stock Ticks Lower: Gauging the Pulse and Future Price Points - Daily Chhattisgarh News
0.16%
0.13%
자본화:
|
볼륨(24시간):